Endocrine Society Advises on Use of Romosozumab for Osteoporosis Endocrine Society Advises on Use of Romosozumab for Osteoporosis

Updated guidance for osteoporosis now includes a recommendation for the use of romosozumab, but only in severe osteoporosis and not in women with a history of myocardial infarction or stroke.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Diabetes & Endocrinology News Source Type: news